Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers

BACKGROUND: Iodine seed implant brachytherapy is indicated for low risk and selected favorable intermediate risk prostate cancers. A percentage of positive biopsies > 50% is usually considered as a contra-indication, and the tumor location could also influence the treatment efficacy. We studied t...

Descripción completa

Detalles Bibliográficos
Autores principales: Meynard, Claire, Huertas, Andres, Dariane, Charles, Toublanc, Sandra, Dubourg, Quentin, Urien, Saik, Timsit, Marc-Olivier, Méjean, Arnaud, Thiounn, Nicolas, Giraud, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938614/
https://www.ncbi.nlm.nih.gov/pubmed/31892338
http://dx.doi.org/10.1186/s13014-019-1449-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938614/
https://www.ncbi.nlm.nih.gov/pubmed/31892338
http://dx.doi.org/10.1186/s13014-019-1449-z

Ejemplares similares